^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
NovoFocus™ NSCLC 2.0 Test

Company:
Novogene
Type:
Other Approval
Related tests:

Details

Evidence
News
NovoFocus™ NSCLC 2.0 Test is a next generation sequencing (NGS)-based assay that analyzes 47 genes related to Non-Small Cell Lung Cancer (NSCLC) for clinically important alterations at the DNA level. It interrogates the complete coding region of 47 genes and introns of 9 genes. It can detect all four types of genomic abnormalities (SNV, InDel, CNV and fusion) and provide targeted therapy options.
Cancer:
Non Small Cell Lung Cancer
Gene:
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), ATR (Ataxia telangiectasia and Rad3-related protein), BRAF (B-raf proto-oncogene), CCND1 (Cyclin D1), CDK4 (Cyclin-dependent kinase 4)
See More ...
Drug:
Tagrisso (osimertinib), Xalkori (crizotinib), gefitinib
Method:
Next-Generation Sequencing (NGS)